We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

European Medicines Agency Approves Olaparib for Women With BRCA-mutant Breast Cancer

News   Apr 23, 2019 | Original story from ICR

 
European Medicines Agency Approves Olaparib for Women With BRCA-mutant Breast Cancer
 
 
Advertisement
 

RELATED ARTICLES

mRNA COVID-19 Vaccine Is Well-Tolerated and Generates Immune Response

News

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

READ MORE

Exploring the Landscape of Pancreatic Tumors With Single-Cell RNA Sequencing

News

A team of researchers has described the individual cells that comprise the pancreatic cancer microenvironment, a critical step in devising new treatment options for patients with this aggressive and difficult-to-treat disease.

READ MORE

Large Study Finds HPV Vaccine Is Effective Against Cervical Cancer

News

Women vaccinated against HPV have a significantly lower risk of developing cervical cancer, and the positive effect is most pronounced for women vaccinated at a young age. That is according to a large study by researchers at Karolinska Institutet in Sweden.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE